Philippe van Rompaey

Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.

H. Munier-Lehmann, V. Vanheusden, Philippe van Rompaey, 2003, Bioorganic & medicinal chemistry letters.

Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.

K. Jacobson, Philippe van Rompaey, S. van Calenbergh, 2005, Bioorganic & medicinal chemistry.

Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.

K. Jacobson, Philippe van Rompaey, S. van Calenbergh, 2004, Bioorganic & medicinal chemistry.

Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.

K. Jacobson, Philippe van Rompaey, S. van Calenbergh, 2006, Journal of medicinal chemistry.

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

G. V. van Dongen, Philippe van Rompaey, H. Vischer, 2013, The Journal of Biological Chemistry.

Chemotaxonomic Features Associated with Flavonoids of Cannabinoid-Free Cannabis (Cannabis sativa subsp. sativa L.) in Relation to hops (Humulus Lupulus L.)

Philippe van Rompaey, P. Sandra, D. de Keukeleire, 2002, Natural product letters.

Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.

Kenneth A Jacobson, K. Jacobson, Philippe van Rompaey, 2003, Journal of medicinal chemistry.

Synthesis of hypermodified adenosine derivatives as selective adenosine A3 receptor ligands.

K. Jacobson, Philippe van Rompaey, S. van Calenbergh, 2006, Bioorganic & medicinal chemistry.